| pubmed-article:12239945 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:12239945 | lifeskim:mentions | umls-concept:C0042776 | lld:lifeskim |
| pubmed-article:12239945 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:12239945 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:12239945 | lifeskim:mentions | umls-concept:C0376705 | lld:lifeskim |
| pubmed-article:12239945 | lifeskim:mentions | umls-concept:C0021747 | lld:lifeskim |
| pubmed-article:12239945 | lifeskim:mentions | umls-concept:C0524910 | lld:lifeskim |
| pubmed-article:12239945 | lifeskim:mentions | umls-concept:C0017431 | lld:lifeskim |
| pubmed-article:12239945 | pubmed:issue | 47 | lld:pubmed |
| pubmed-article:12239945 | pubmed:dateCreated | 2002-9-20 | lld:pubmed |
| pubmed-article:12239945 | pubmed:abstractText | Interferon treatment is more effective in patients with chronic hepatitis C infected with genotype 2a virus than those with genotype 1b virus. We analyzed patients with chronic hepatitis C treated by interferon in our clinics to develop a more effective regimen of interferon treatment for patients with genotype 2 virus infection. | lld:pubmed |
| pubmed-article:12239945 | pubmed:language | eng | lld:pubmed |
| pubmed-article:12239945 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12239945 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:12239945 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12239945 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12239945 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12239945 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:12239945 | pubmed:issn | 0172-6390 | lld:pubmed |
| pubmed-article:12239945 | pubmed:author | pubmed-author:KishimaYoshih... | lld:pubmed |
| pubmed-article:12239945 | pubmed:author | pubmed-author:YoshidaKenyaK | lld:pubmed |
| pubmed-article:12239945 | pubmed:author | pubmed-author:EnomotoHirayu... | lld:pubmed |
| pubmed-article:12239945 | pubmed:author | pubmed-author:YamamotoMitsu... | lld:pubmed |
| pubmed-article:12239945 | pubmed:author | pubmed-author:KurodaToshifu... | lld:pubmed |
| pubmed-article:12239945 | pubmed:author | pubmed-author:ItoHiroakiH | lld:pubmed |
| pubmed-article:12239945 | pubmed:author | pubmed-author:NakamuraHidej... | lld:pubmed |
| pubmed-article:12239945 | pubmed:author | pubmed-author:MatsudaMasahi... | lld:pubmed |
| pubmed-article:12239945 | pubmed:author | pubmed-author:NoguchiSanaiS | lld:pubmed |
| pubmed-article:12239945 | pubmed:author | pubmed-author:OgawaHiyoyuki... | lld:pubmed |
| pubmed-article:12239945 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:12239945 | pubmed:volume | 49 | lld:pubmed |
| pubmed-article:12239945 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:12239945 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:12239945 | pubmed:pagination | 1373-6 | lld:pubmed |
| pubmed-article:12239945 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
| pubmed-article:12239945 | pubmed:meshHeading | pubmed-meshheading:12239945... | lld:pubmed |
| pubmed-article:12239945 | pubmed:meshHeading | pubmed-meshheading:12239945... | lld:pubmed |
| pubmed-article:12239945 | pubmed:meshHeading | pubmed-meshheading:12239945... | lld:pubmed |
| pubmed-article:12239945 | pubmed:meshHeading | pubmed-meshheading:12239945... | lld:pubmed |
| pubmed-article:12239945 | pubmed:meshHeading | pubmed-meshheading:12239945... | lld:pubmed |
| pubmed-article:12239945 | pubmed:meshHeading | pubmed-meshheading:12239945... | lld:pubmed |
| pubmed-article:12239945 | pubmed:meshHeading | pubmed-meshheading:12239945... | lld:pubmed |
| pubmed-article:12239945 | pubmed:meshHeading | pubmed-meshheading:12239945... | lld:pubmed |
| pubmed-article:12239945 | pubmed:meshHeading | pubmed-meshheading:12239945... | lld:pubmed |
| pubmed-article:12239945 | pubmed:meshHeading | pubmed-meshheading:12239945... | lld:pubmed |
| pubmed-article:12239945 | pubmed:meshHeading | pubmed-meshheading:12239945... | lld:pubmed |
| pubmed-article:12239945 | pubmed:meshHeading | pubmed-meshheading:12239945... | lld:pubmed |
| pubmed-article:12239945 | pubmed:meshHeading | pubmed-meshheading:12239945... | lld:pubmed |
| pubmed-article:12239945 | pubmed:meshHeading | pubmed-meshheading:12239945... | lld:pubmed |
| pubmed-article:12239945 | pubmed:articleTitle | Interferon treatment for patients with chronic hepatitis C infected with high viral load of genotype 2 virus. | lld:pubmed |
| pubmed-article:12239945 | pubmed:affiliation | Department of Molecular Medicine, Osaka University Graduate School of Medicine, Yamada-oka 2-2, Suita City, Osaka 565-0871, Japan. | lld:pubmed |
| pubmed-article:12239945 | pubmed:publicationType | Journal Article | lld:pubmed |
